Skip to main content
. Author manuscript; available in PMC: 2015 Apr 1.
Published in final edited form as: J Am Geriatr Soc. 2014 Mar 17;62(4):607–614. doi: 10.1111/jgs.12749

Table 1.

Metabolic effects of AEX+WL and WL

AEX+WL (n=37) WL (n=40) Intervention Comparison

Pre Post Pre Post
Age (yr) 60 ± 1 --- 61 ± 1 --- NS
Weight (kg) 85.2 ± 2.4 78.2 ± 2.2 87.2 ± 2.1 80.0 ± 2.0 NS
BMI (kg/m2) 32 ± 1 30 ± 1 33 ± 1 30 ± 1 NS
Waist circumference (cm) 96.3 ± 2.4 91.8 ± 2.5 96.7 ± 1.6 91.0 ± 1.7 NS
Percent body fat 47.1 ± 0.9 43.5 ± 1.1 47.8 ± 0.6 44.8 ± 0.8 NS
Fat mass (kg) 40.6 ± 1.7 34.8 ± 1.7 42.4 ± 1.5 36.7 ± 1.4 NS
Fat-free mass (kg) 45.0 ± 1.1 44.1 ± 0.9* 45.4 ± 0.8 43.9 ± 0.8 NS
VO2max (l/min) 1.78 ± 0.08 a 2.03 ± 0.10 1.50 ± 0.06 1.48 ± 0.05 P<0.01
Visceral fat (cm2) 145.8 ± 13.6 125.6 ± 11.7 141.8 ± 8.8 120.2 ± 6.9 NS
Subcutaneous abdominal fat (cm2) 458.4 ± 24.4 390.4 ± 27.8 432.0 ± 23.8 379.8 ± 21.4 NS
Total abdominal fat (cm2) 598.7 ± 34.2 505.9 ± 35.8 567.6 ± 24.6 493.4 ± 23.3 NS
Total abdominal/Visceral 4.97 ± 0.38 5.08 ± 0.40 4.64 ± 0.34 4.73 ± 0.35 NS
Sagittal Diameter (mm) 25.8 ± 0.7 23.8 ± 0.7 25.3 ± 0.5 23.4 ± 0.5 NS
Systolic BP (mmHg) 123 ± 2a 118 ± 2 119 ± 1 116 ± 2* NS
Diastolic BP (mmHg) 69 ± 1 67 ± 1 68 ± 1 65 ± 1* NS
TG (mg/dl) 118 ± 7 101 ± 5 122 ± 8 111 ± 8 NS
Total Cholesterol (mg/dl) 193 ± 6 188 ± 5 200 ± 5 193 ± 5 NS
HDL-C (mg/dl) 51 ± 2 55 ± 2 56 ± 2 58 ± 2 NS
HDL3-C (mg/dl) 41 ± 1 a 44 ±1* 45 ± 1 44 ± 1 NS
LDL-C (mg/dl) 118 ± 5 113 ± 4 119 ± 5 114 ± 4 NS
Fasting glucose (mmol/l) 5.2 ± 0.1 5.1 ± 0.1* 5.4 ± 0.1 5.0 ± 0.1 NS
Glucose@120min (mmol/l) 7.3 ± 0.3 6.8 ± 0.2 6.9 ± 0.3 6.7 ±0.3 NS
Fasting insulin (pmol/l) 84 ± 8 69 ± 5 88 ± 6 66 ± 4 NS
HOMA-IR 2.9 ± 0.3 2.3 ± 0.2 3.0 ± 0.2 2.1 ± 0.1
M (mg/kg/min) 6.2 ± 0.3 7.4 ± 0.4 6.0 ± 0.3 6.6 ± 0.3 NS
M (μmol/kgFFM/min) 64.6 ± 3.3 71.1 ± 3.1* 63.8 ± 3.1 68.1 ± 3.6 NS

VO2max = maximal oxygen consumption, BP = blood pressure, TG= triglycerides, HDL-C = high density lipoprotein cholesterol, LDL-C = low density lipoprotein cholesterol, HOMA-IR = Homeostasis model assessment-insulin resistance, M = glucose utilization.NS, nonsignificant. Values are mean ± SEM. Baseline differences tested between groups;

a

P<0.05.

Significantly different pre vs. post intervention:

*

P<0.05;

P<0.01;

P<0.001.